• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病理性分级预测嗜铬细胞瘤和副神经节瘤的转移。

Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma.

出版信息

Endocr Relat Cancer. 2014 May 6;21(3):405-14. doi: 10.1530/ERC-13-0494. Print 2014 Jun.

DOI:10.1530/ERC-13-0494
PMID:24521857
Abstract

Phaeochromocytomas (PHEO) and paragangliomas are rare catecholamine-producing tumours. Although 10-30% of these tumours metastasise, histopathological criteria to discriminate malignant from benign tumours have not been established; therefore, reliable histopathological markers predicting metastasis are urgently required. A total of 163 tumours, including 40 metastatic tumours, collected by the Phaeochromocytoma Study Group in Japan (PHEO-J) were analysed using a system called grading system for adrenal phaeochromocytoma and paraganglioma (GAPP). The tumours were scored based on GAPP criteria as follows: histological pattern, cellularity, comedo-type necrosis, capsular/vascular invasion, Ki67 labelling index and catecholamine type. All tumours were scored from 0 to 10 points and were graded as one of the three types: well-differentiated (WD, 0-2 points), moderately differentiated (MD, 3-6 points) and poorly differentiated (PD, 7-10 points). GAPP scores of the non-metastatic and metastatic groups were 2.08±0.17 and 5.33±0.43 (mean±s.e.m., P<0.001) respectively. There was a significant negative correlation between the GAPP score and the interval until metastasis (r=-0.438, P<0.01). The mean number of years until metastasis after the initial operation was 5.5±2.6 years. The study included 111 WD, 35 MD and 17 PD types. The five-year survival of these groups was 100, 66.8 and 22.4% respectively. In addition, negative immunoreactivity for succinate dehydrogenase gene subunit B (SDHB) was observed in 13 (8%) MD or PD tumours and ten of the 13 (77%) had metastases. Our data indicate that a combination of GAPP classification and SDHB immunohistochemistry might be useful for the prediction of metastasis in these tumours.

摘要

嗜铬细胞瘤(PHEO)和副神经节瘤是罕见的儿茶酚胺产生肿瘤。尽管这些肿瘤中有 10-30%发生转移,但尚未建立用于区分良恶性肿瘤的组织病理学标准;因此,迫切需要可靠的组织病理学标志物来预测转移。使用一种名为肾上腺嗜铬细胞瘤和副神经节瘤分级系统(GAPP)的系统分析了日本嗜铬细胞瘤研究组(PHEO-J)收集的 163 个肿瘤,包括 40 个转移性肿瘤。根据 GAPP 标准对肿瘤进行评分,如下所示:组织学模式、细胞密度、粉刺样坏死、包膜/血管侵犯、Ki67 标记指数和儿茶酚胺类型。所有肿瘤的评分范围为 0 至 10 分,并分为以下三种类型之一:分化良好(WD,0-2 分)、中度分化(MD,3-6 分)和低分化(PD,7-10 分)。非转移性和转移性组的 GAPP 评分分别为 2.08±0.17 和 5.33±0.43(平均值±s.e.m.,P<0.001)。GAPP 评分与转移间隔时间呈显著负相关(r=-0.438,P<0.01)。初始手术后转移的平均时间为 5.5±2.6 年。该研究包括 111 例 WD、35 例 MD 和 17 例 PD 型肿瘤。这些组的五年生存率分别为 100%、66.8%和 22.4%。此外,13 例(8%)MD 或 PD 肿瘤的琥珀酸脱氢酶基因亚单位 B(SDHB)免疫反应阴性,其中 10 例(77%)发生转移。我们的数据表明,GAPP 分类和 SDHB 免疫组织化学的组合可能有助于预测这些肿瘤的转移。

相似文献

1
Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma.病理性分级预测嗜铬细胞瘤和副神经节瘤的转移。
Endocr Relat Cancer. 2014 May 6;21(3):405-14. doi: 10.1530/ERC-13-0494. Print 2014 Jun.
2
Validation of pathological grading systems for predicting metastatic potential in pheochromocytoma and paraganglioma.嗜铬细胞瘤和副神经节瘤转移潜能预测病理分级系统的验证
PLoS One. 2017 Nov 8;12(11):e0187398. doi: 10.1371/journal.pone.0187398. eCollection 2017.
3
Predicting Metastatic Potential in Pheochromocytoma and Paraganglioma: A Comparison of PASS and GAPP Scoring Systems.预测嗜铬细胞瘤和副神经节瘤的转移潜能:PASS 和 GAPP 评分系统的比较。
J Clin Endocrinol Metab. 2020 Dec 1;105(12):e4661-70. doi: 10.1210/clinem/dgaa608.
4
Histological grading of adrenal and extra-adrenal pheochromocytomas and relationship to prognosis: a clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors.肾上腺及肾上腺外嗜铬细胞瘤的组织学分级及其与预后的关系:116例肾上腺嗜铬细胞瘤和30例肾上腺外交感神经节旁瘤(包括38例恶性肿瘤)的临床病理分析
Endocr Pathol. 2005 Spring;16(1):23-32. doi: 10.1385/ep:16:1:023.
5
Neuroendocrine cancer. Closing the GAPP on predicting metastases.神经内分泌癌。填补预测转移的 GAPP 空白。
Nat Rev Endocrinol. 2014 Jun;10(6):315-6. doi: 10.1038/nrendo.2014.41. Epub 2014 Apr 1.
6
Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas.琥珀酸脱氢酶B基因突变可预测恶性嗜铬细胞瘤或副神经节瘤患者的生存率。
J Clin Endocrinol Metab. 2007 Oct;92(10):3822-8. doi: 10.1210/jc.2007-0709. Epub 2007 Jul 24.
7
Overexpression of the insulin-like growth factor 1 receptor (IGF-1R) is associated with malignancy in familial pheochromocytomas and paragangliomas.胰岛素样生长因子 1 受体(IGF-1R)的过度表达与家族性嗜铬细胞瘤和副神经节瘤的恶性程度相关。
Clin Endocrinol (Oxf). 2013 Nov;79(5):623-30. doi: 10.1111/cen.12205. Epub 2013 Apr 13.
8
SDHB mutation status and tumor size but not tumor grade are important predictors of clinical outcome in pheochromocytoma and abdominal paraganglioma.琥珀酸脱氢酶B(SDHB)突变状态和肿瘤大小而非肿瘤分级是嗜铬细胞瘤和腹部副神经节瘤临床预后的重要预测指标。
Surgery. 2017 Jan;161(1):230-239. doi: 10.1016/j.surg.2016.05.050. Epub 2016 Nov 10.
9
KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma.KI-67和hTERT的表达有助于区分恶性和良性嗜铬细胞瘤及副神经节瘤。
Mod Pathol. 2003 Mar;16(3):246-55. doi: 10.1097/01.MP.0000056982.07160.E3.
10
The diagnosis and management of malignant phaeochromocytoma and paraganglioma.恶性嗜铬细胞瘤和副神经节瘤的诊断与管理
Endocr Relat Cancer. 2007 Sep;14(3):569-85. doi: 10.1677/ERC-07-0074.

引用本文的文献

1
Late-Onset Bone Metastasis 46 Years After Initial Surgery for Pheochromocytoma: A Case Report.嗜铬细胞瘤初次手术后46年发生的迟发性骨转移:一例报告
IJU Case Rep. 2025 Aug 13;8(5):533-538. doi: 10.1002/iju5.70086. eCollection 2025 Sep.
2
Case report: Synchronous bladder and retroperitoneal paragangliomas: an extremely rare entity.病例报告:同步性膀胱和腹膜后副神经节瘤:一种极其罕见的疾病。
Front Oncol. 2025 Aug 13;15:1593934. doi: 10.3389/fonc.2025.1593934. eCollection 2025.
3
Balancing Surgery and Radiosurgery in Jugulotympanic Paragangliomas.
颈静脉鼓室副神经节瘤手术与放射外科的平衡
Cureus. 2025 Jul 9;17(7):e87609. doi: 10.7759/cureus.87609. eCollection 2025 Jul.
4
Prediction of Metastasis in Paragangliomas and Pheochromocytomas Using Machine Learning Models: Explainability Challenges.使用机器学习模型预测副神经节瘤和嗜铬细胞瘤的转移:可解释性挑战
Sensors (Basel). 2025 Jul 4;25(13):4184. doi: 10.3390/s25134184.
5
Paraganglioma of the spermatic cord: A rare tumor with unique imaging findings and diagnostic challenges.精索副神经节瘤:一种具有独特影像学表现和诊断挑战的罕见肿瘤。
GHM Open. 2025 Jun 30;5(1):43-46. doi: 10.35772/ghmo.2024.01010.
6
Metastatic Malignant Phaeochromocytoma in Ascitic Fluid: Cytological Diagnosis of a Rare Entity.腹水中的转移性恶性嗜铬细胞瘤:一种罕见实体的细胞学诊断
Cytopathology. 2025 Jun 30;36(5):539-43. doi: 10.1111/cyt.70003.
7
Prognostic markers in pheochromocytomas/paragangliomas: the role of histopathology, SDHB, MAML3 and MCM6 expression.嗜铬细胞瘤/副神经节瘤的预后标志物:组织病理学、SDHB、MAML3和MCM6表达的作用
J Endocrinol Invest. 2025 May 30. doi: 10.1007/s40618-025-02610-8.
8
GLP- 1R status using validated monoclonal antibody in 689 cases of neuroendocrine neoplasm and its correlation with somatostatin receptor scintigraphy, insulin production, and histological grades.使用经过验证的单克隆抗体检测689例神经内分泌肿瘤中的GLP-1R状态及其与生长抑素受体闪烁显像、胰岛素分泌和组织学分级的相关性。
Virchows Arch. 2025 Apr 26. doi: 10.1007/s00428-025-04098-2.
9
[A case report of malignant paraganglioma with lymph node and liver metastasis in the jugular foramen area].[一例颈静脉孔区恶性副神经节瘤伴淋巴结及肝转移的病例报告]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2025 May;39(5):486-487;490. doi: 10.13201/j.issn.2096-7993.2025.05.017.
10
Maximum diameter of carotid body tumor as an independent risk factor for a GAPP score of ≥5: an ultrasound study.颈动脉体瘤最大直径作为GAPP评分≥5的独立危险因素:一项超声研究
Quant Imaging Med Surg. 2025 Apr 1;15(4):2881-2888. doi: 10.21037/qims-24-890. Epub 2025 Mar 17.